Matches in SemOpenAlex for { <https://semopenalex.org/work/W3206147585> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W3206147585 endingPage "1595" @default.
- W3206147585 startingPage "1589" @default.
- W3206147585 abstract "Purpose: To investigate hypoxia-induced gene expression pattern in doxorubicin-resistant human breast cancer cells (MCF7).Methods: Human breast cancer cells (MCF7) were exposed to 60 episodes of 8 h hypoxia thrice a week for three months. Chemo-resistance to doxorubicin was assessed using 3-(4,5-dimethylthiazol-2- yl)-2, 5-diphenyl tetrazolium bromide (MTT) cell proliferation assay. Real-time quantitative polymerase chain reaction (qRT-PCR) assay was performed to assess gene expression pattern in doxorubicinresistant cells on exposure to hypoxia.Results: Hypoxia significantly increased the resistance of MCF7 cells to doxorubicin, with a maximum of 16.42-fold enhancement after 25 episodes of 8-h hypoxia, while the resistance thereafter significantly decreased with prolonged episodes of hypoxia (p < 0.05). Gene expression analysis revealed significant changes in 42 genes. The expressions of 10 of these genes were significantly upregulated, while those of 32 genes were significantly down-regulated (p < 0.05). Cytochrome P450 family 1, subfamily A, member1 (CYP1A1) was the most conspicuous upregulated gene (13.32-fold), while breast cancer gene 1 (BRCA1) was the most down-regulated (8.23-fold). Gene expression analysis after 60 episodes of 8-h hypoxia revealed the upregulation of CYP1A1 (5.77-fold). Similarly, 27 genes were significantly down-regulated, with BRCA2 as the most down-regulated gene (8.11-fold). Topoisomerase (DNA) II alpha (TOP2A) was the most down-regulated among genes involved in drug metabolism and resistance (6.37-fold), while cyclin-dependent kinase 2 (CDK2) was the most profoundly downregulated among genes involved in cell cycle regulation (3.56-fold).Conclusion: These results indicate that development of resistance to doxorubicin by MCF7 cells after short-term hypoxia results from the upregulation of genes responsible for the metabolism of doxorubicin and for shifting the cells to alternative pathway driven principally by EGF and ESR2. The observed down-regulation is an adaptation of the MCF7 cells to survive under long-term hypoxia." @default.
- W3206147585 created "2021-10-25" @default.
- W3206147585 creator A5070151087 @default.
- W3206147585 creator A5074594330 @default.
- W3206147585 creator A5083818325 @default.
- W3206147585 date "2019-01-01" @default.
- W3206147585 modified "2023-09-26" @default.
- W3206147585 title "Hypoxia-induced gene expression pattern in doxorubicin resistant MCF7 cells" @default.
- W3206147585 doi "https://doi.org/10.4314/tjpr.v18i8" @default.
- W3206147585 hasPublicationYear "2019" @default.
- W3206147585 type Work @default.
- W3206147585 sameAs 3206147585 @default.
- W3206147585 citedByCount "0" @default.
- W3206147585 crossrefType "journal-article" @default.
- W3206147585 hasAuthorship W3206147585A5070151087 @default.
- W3206147585 hasAuthorship W3206147585A5074594330 @default.
- W3206147585 hasAuthorship W3206147585A5083818325 @default.
- W3206147585 hasConcept C104317684 @default.
- W3206147585 hasConcept C127561419 @default.
- W3206147585 hasConcept C150194340 @default.
- W3206147585 hasConcept C153911025 @default.
- W3206147585 hasConcept C178790620 @default.
- W3206147585 hasConcept C185592680 @default.
- W3206147585 hasConcept C2776694085 @default.
- W3206147585 hasConcept C2781303535 @default.
- W3206147585 hasConcept C502942594 @default.
- W3206147585 hasConcept C540031477 @default.
- W3206147585 hasConcept C54355233 @default.
- W3206147585 hasConcept C55493867 @default.
- W3206147585 hasConcept C7836513 @default.
- W3206147585 hasConcept C86803240 @default.
- W3206147585 hasConceptScore W3206147585C104317684 @default.
- W3206147585 hasConceptScore W3206147585C127561419 @default.
- W3206147585 hasConceptScore W3206147585C150194340 @default.
- W3206147585 hasConceptScore W3206147585C153911025 @default.
- W3206147585 hasConceptScore W3206147585C178790620 @default.
- W3206147585 hasConceptScore W3206147585C185592680 @default.
- W3206147585 hasConceptScore W3206147585C2776694085 @default.
- W3206147585 hasConceptScore W3206147585C2781303535 @default.
- W3206147585 hasConceptScore W3206147585C502942594 @default.
- W3206147585 hasConceptScore W3206147585C540031477 @default.
- W3206147585 hasConceptScore W3206147585C54355233 @default.
- W3206147585 hasConceptScore W3206147585C55493867 @default.
- W3206147585 hasConceptScore W3206147585C7836513 @default.
- W3206147585 hasConceptScore W3206147585C86803240 @default.
- W3206147585 hasIssue "8" @default.
- W3206147585 hasLocation W32061475851 @default.
- W3206147585 hasOpenAccess W3206147585 @default.
- W3206147585 hasPrimaryLocation W32061475851 @default.
- W3206147585 hasRelatedWork W1011266069 @default.
- W3206147585 hasRelatedWork W1541512955 @default.
- W3206147585 hasRelatedWork W1967245868 @default.
- W3206147585 hasRelatedWork W2048463107 @default.
- W3206147585 hasRelatedWork W2083441068 @default.
- W3206147585 hasRelatedWork W2107641193 @default.
- W3206147585 hasRelatedWork W2107947815 @default.
- W3206147585 hasRelatedWork W2145641211 @default.
- W3206147585 hasRelatedWork W2224391531 @default.
- W3206147585 hasRelatedWork W2386016531 @default.
- W3206147585 hasRelatedWork W2393677892 @default.
- W3206147585 hasRelatedWork W2404861567 @default.
- W3206147585 hasRelatedWork W2405395177 @default.
- W3206147585 hasRelatedWork W2438095353 @default.
- W3206147585 hasRelatedWork W2964426946 @default.
- W3206147585 hasRelatedWork W3005182722 @default.
- W3206147585 hasRelatedWork W3005254414 @default.
- W3206147585 hasRelatedWork W3119348997 @default.
- W3206147585 hasRelatedWork W3148256673 @default.
- W3206147585 hasRelatedWork W330226713 @default.
- W3206147585 hasVolume "18" @default.
- W3206147585 isParatext "false" @default.
- W3206147585 isRetracted "false" @default.
- W3206147585 magId "3206147585" @default.
- W3206147585 workType "article" @default.